BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join

Immuno 2023

Immuno 2023

Event Date: March 28, 2023 - March 29, 2023

Location: United Kingdom, London

Website: Link

Immuno 2023: Oxford Global is proud to present Immuno UK: In-Person, 28-29th March 2023, London. This unmissable event will host UK-based pharmaceutical giants, top biotech, and internationally renowned academic institutions, to share trailblazing advancements in immuno-oncology and autoimmunity.  

Guided by industry leaders, Immuno UK will focus on rapidly growing therapeutic modalities, and highlight how studies into the tumour microenvironment are vastly improving our understanding of tumour biology, informing the design and delivery of future immunotherapies. We aim to showcase current translational approaches to ensure the success of these treatments and place patient safety at the forefront of immunotherapy. 

Our Biomarkers stream we will be exploring how upcoming regulatory changes in the EU and UK will affect the evolving landscape of precision medicine, and what this could mean for the industries research. Senior level executives from big pharma will also be sharing emerging biomarker strategies driving therapies to the clinic. 

With a dedicated full day stream exploring autoimmunity, Immuno UK will also feature talks on innovative new therapies and their journeys to the clinic. Presentations will focus on the push to evolve from immunosuppressive treatment regimens, and instead develop therapies that can restore a healthy immune system, vastly improving patient outcomes. 

 

Key Speakers Include: 

  • Patrick Fivey, Director Precision Medicine Policy, AstraZeneca 

  • Sonia Iyer, Associate Director Immuno-Oncology Strategy, Translation Research, AstraZeneca 

  • James Legg, Senior Vice President, Research and Early Development, Mestag Therapeutics 

  • Dominik Hartl, Chief Medical Officer, Quell Therapeutics 

  • Kairbaan Hodivala-Dilke, Deputy Director, Barts Cancer Institute 

 

With over 45 presentations and panel discussions over two-days, Immuno UK will provide an ideal space to engage in high level business and scientific discussions. Join over 400 senior level delegates from the UK and benefit from global networking opportunities through our online platform. For more information about the programme and registration please contact us at d.dalby@oxfordglobal.co.uk. 

← Back to List of Events

#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials
List of Events
Calendar of Events

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.